Tagraxofusp-resistant AML cells (THP1) displayed CpG motifs hypermethylation in the promoter region of DPH1, and azacitidine treatment suppressed the CpG DNA hypermethylation that restored DPH1 expression. Here, DPH1 is linked to acute myeloid leukemia.